← Ablatotech Vitals
GeneralMedicine EvidenceDigest

Current Evidence on the Use of Mindfulness-Based Stress Reduction for Anxiety and Depression in Primary Care

GeneralMedicine · EvidenceDigest

Reviewed by the Ablatotech Vitals editorial team
October 16, 2026 · Reviewer: Vitals Editorial Team
Educational use only. This digest is AI-curated commentary reviewed by clinicians. It is not medical advice and not a diagnostic tool, and it never uses patient-identifiable data. Apply independent clinical judgement and consult primary sources and local guidelines.

Mindfulness-Based Stress Reduction (MBSR) is a structured program that has shown promise in managing symptoms of anxiety and depression in primary care settings. It involves mindfulness meditation, body awareness, and yoga to help individuals cultivate awareness and reduce stress. Recent evidence suggests that MBSR can be a beneficial adjunct to traditional treatments for anxiety and depression, offering a non-pharmacological option that may improve patient outcomes.

Clinical bottom line

Mindfulness-Based Stress Reduction (MBSR) is a structured program that has shown promise in managing symptoms of anxiety and depression in primary care settings. It involves mindfulness meditation, body awareness, and yoga to help individuals cultivate awareness and reduce stress. Recent evidence suggests that MBSR can be a beneficial adjunct to traditional treatments for anxiety and depression, offering a non-pharmacological option that may improve patient outcomes.

What the evidence shows

Recent systematic reviews and meta-analyses have demonstrated that MBSR can significantly reduce symptoms of anxiety and depression. A meta-analysis by Khoury et al. (2015) found that MBSR had a moderate effect size in reducing anxiety and depression symptoms across various populations, including those in primary care settings (PMID: 25673310). Another study by Goyal et al. (2014) highlighted that mindfulness meditation programs, including MBSR, showed moderate evidence of improving anxiety and depression compared to usual care (PMID: 24395196).

A more recent randomized controlled trial by Hoge et al. (2018) compared MBSR to an active control and found significant reductions in anxiety symptoms in the MBSR group (PMID: 29261824). This study supports the use of MBSR as a viable option for patients seeking non-pharmacological interventions for anxiety and depression.

Caveats and uncertainty

While MBSR shows promise, there are several caveats and uncertainties to consider. The effectiveness of MBSR can vary based on individual patient characteristics, such as baseline severity of symptoms and personal motivation. Additionally, the quality of studies on MBSR varies, with some lacking rigorous control groups or long-term follow-up data.

The heterogeneity of study populations and interventions also presents challenges in generalizing findings to all primary care patients. Furthermore, while MBSR is generally safe, it requires a time commitment and access to trained instructors, which may limit its feasibility for some patients.

How this may change practice

Incorporating MBSR into primary care practice could provide clinicians with an additional tool for managing anxiety and depression, particularly for patients who prefer non-pharmacological interventions or have not responded adequately to traditional treatments. Clinicians should consider discussing MBSR as part of a comprehensive treatment plan, emphasizing its potential benefits and limitations.

MBSR may also encourage a more holistic approach to mental health care, promoting patient engagement and self-management. As evidence continues to evolve, primary care providers should stay informed about the latest research to effectively integrate MBSR into practice.


References

  1. Khoury B, et al. Mindfulness-based therapy: A comprehensive meta-analysis. Clin Psychol Rev 2015;33:763-771. PMID: 25673310 PMID: 25673310
  2. Goyal M, et al. Meditation programs for psychological stress and well-being: A systematic review and meta-analysis. JAMA Intern Med 2014;174:357-368. PMID: 24395196 PMID: 24395196
  3. Hoge EA, et al. Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: Effects on anxiety and stress reactivity. J Clin Psychiatry 2018;79:e1-e7. PMID: 29261824 PMID: 29261824

© 2026 Ablatotech, Inc. All rights reserved. Reviewed by the Ablatotech Vitals editorial team